Intracellular signals of T cell costimulation

Cellular and Molecular Immunology

Volumn 5, Issue 4, 2008, Pages 239-247

  Song, Jianxun ^a   Lei, Fengyang Tylan ^a   Xiong, Xiaofang ^a   Haque, Rizwanul ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

costimulation; signal transduction; T cell development

Indexed keywords

AURORA KINASE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; MICROTUBULE ASSOCIATED PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE;

ANIMAL; ANTIGEN PRESENTING CELL; CELL PROLIFERATION; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIGEN-PRESENTING CELLS; CELL PROLIFERATION; CYTOKINES; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MICROTUBULE-ASSOCIATED PROTEINS; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 55249097716     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2008.30     Document Type: Review

References (89)

1. Frauwirth KA, Thompson CB. Activation and inhibition of lymphocytes by cost (Pubitemid 34141801)
2. Nurieva R, Thomas S, Nguyen T, et al. T-cell tolerance or function is determined by combinatorial costimulatory signals. EMBO J. 2006;25:2623-2633. (Pubitemid 44012244)
3. Lee SW, Park Y, So T, et al. Identification of regulatory functions for 4-1BB and 4-1BBL in myelopoiesis and the development of dendritic cells. Nat Immunol. 2008;9:917-926.
4. Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat Rev Immunol. 2003;3:609-620. (Pubitemid 37328664)
5. Muller N, van den Brandt J, Odoardi F, et al. A CD28 superagonistic antibody elicits 2 functionally distinct waves of T cell activation in rats. J Clin Invest. 2008;118:1405-1416. (Pubitemid 351500434)
6. Ochi S, Shinohara M, Sato K, et al. Pathological role of osteoclast costimulation in arthritis-induced bone loss. Proc Natl Acad Sci U S A. 2007;104:11394-11399. (Pubitemid 47175151)
7. Thebeau LG, Vagvala SP, Wong YM, Morrison LA. B7 costimulation molecules expressed from the herpes simplex virus 2 genome rescue immune induction in B7-deficient mice. J Virol. 2007;81:12200-12209. (Pubitemid 350085835)
8. Seshasayee D, Lee WP, Zhou M, et al. In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation. J Clin Invest. 2007;117:3868-3878. (Pubitemid 350224096)
9. Piconese S, Valzasina B, Colombo MP. OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection. J Exp Med. 2008;205:825-839. (Pubitemid 351549881)
10. + T cell-mediated CD28/ CD154-independent rejection. J Immunol. 2008;180:7203-7211.
11. + T cells facilitate the induction of T cell anergy. J Immunol. 2001;167:4271-4275. (Pubitemid 32954301)
12. Thomas RM, Gao L, Wells AD. Signals from CD28 induce stable epigenetic modification of the IL-2 promoter. J Immunol. 2005;174:4639-4646.
13. Wu LX, La Rose J, Chen L, et al. CD28 regulates the translation of Bcl-xL via the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway. J Immunol. 2005;174:180-194. (Pubitemid 40007404)
14. Negishi T, Kato Y, Ooneda O, et al. Effects of aryl hydrocarbon receptor signaling on the modulation of TH1/TH2 balance. J Immunol. 2005;175:7348-7356. (Pubitemid 41713431)
15. Song J, Salek-Ardakani S, Rogers PR, Cheng M, Van Parijs L, Croft M. The costimulation-regulated duration of PKB activation controls T cell longevity. Nat Immunol. 2004;5:150-158. (Pubitemid 38208356)
16. Song J, So T, Cheng M, Tang X, Croft M. Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion. Immunity. 2005;22:621-631. (Pubitemid 40719197)
17. Gaspal F, Bekiaris V, Kim MY, et al. Critical synergy of CD30 and OX40 signals in CD4 T cell homeostasis and Th1 immunity to Salmonella. J Immunol. 2008;180:2824-2829.
18. C VS, Babar SM, Song EJ, Oh E, Yoo YS. Kinetic analysis of the MAPK and PI3K/Akt signaling pathways. Mol Cells. 2008;25:397-406.
19. Watanabe R, Harada Y, Takeda K, et al. Grb2 and Gads exhibit different interactions with CD28 and play distinct roles in CD28-mediated costimulation. J Immunol. 2006;177:1085-1091. (Pubitemid 44036611)
20. Harada Y, Tokushima M, Matsumoto Y, et al. Critical requirement for the membrane-proximal cytosolic tyrosine residue for CD28-mediated costimulation in vivo. J Immunol. 2001;166:3797-3803. (Pubitemid 32224904)
21. Okkenhaug K, Wu L, Garza KM, et al. A point mutation in CD28 distinguishes proliferative signals from survival signals. Nat Immunol. 2001;2:325-332. (Pubitemid 33706343)
22. Berg-Brown NN, Gronski MA, Jones RG, et al. PKCθ signals activation versus tolerance in vivo. J Exp Med. 2004;199:743-752. (Pubitemid 38375194)
23. Garcon F, Patton DT, Emery JL, et al. CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer. Blood. 2008;111:1464-1471. (Pubitemid 351213434)
24. Levin SE, Zhang C, Kadlecek TA, Shokat KM, Weiss A. Inhibition of ZAP-70 kinase activity via an analog-sensitive allele blocks T cell receptor and CD28 superagonist signaling. J Biol Chem. 2008;283:15419-15430.
25. + T cells by leukemia impairs isotype switching in normal B cells. Nat Immunol. 2001;2:150-156. (Pubitemid 33707935)
26. Ma BY, Mikolajczak SA, Danesh A, et al. The expression and the regulatory role of OX40 and 4-1BB heterodimer in activated human T cells. Blood. 2005;106:2002-2010. (Pubitemid 41291713)
27. Nocentini G, Riccardi C. GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur J Immunol. 2005;35:1016-1022. (Pubitemid 40542207)
28. Biswas DK, Martin KJ, McAlister C, et al. Apoptosis caused by chemotherapeutic inhibition of nuclear factor-κB activation. Cancer Res. 2003;63:290-295. (Pubitemid 36152482)
29. So T, Salek-Ardakani S, Nakano H, Ware CF, Croft M. TNF receptor-associated factor 5 limits the induction of Th2 immune responses. J Immunol. 2004;172:4292-4297. (Pubitemid 38375243)
30. Hauer J, Puschner S, Ramakrishnan P, et al. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-κB pathway by TRAF-binding TNFRs. Proc Natl Acad Sci U S A. 2005;102:2874-2879. (Pubitemid 40299884)
31. Takaori-Kondo A, Hori T, Fukunaga K, Morita R, Kawamata S, Uchiyama T. Both amino- and carboxyl-terminal domains of TRAF3 negatively regulate NF-κB activation induced by OX40 signaling. Biochem Biophys Res Commun. 2000;272:856-863. (Pubitemid 30420726)
32. Song J, So T, Croft M. Activation of NF-κB1 by OX40 contributes to antigen-driven T cell expansion and survival. J Immunol. 2008;180:7240-7248.
33. Song J, Salek-Ardakani S, So T, Croft M. The kinases aurora B and mTOR regulate the G1-S cell cycle progression of T lymphocytes. Nat Immunol. 2007;8:64-73. (Pubitemid 46242360)
34. + T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response. J Immunol. 2008;180:1148-1157.
35. Ford ML, Koehn BH, Wagener ME, et al. Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation. J Exp Med. 2007;204:299-309. (Pubitemid 46294546)
36. Amadi-Obi A, Yu CR, Liu X, et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med. 2007;13:711-718. (Pubitemid 46889754)
37. Mucida D, Park Y, Kim G, et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science. 2007;317:256-260. (Pubitemid 47076203)
38. Liu XK, Clements JL, Gaffen SL. Signaling through the murine T cell receptor induces IL-17 production in the absence of costimulation, IL-23 or dendritic cells. Mol Cells. 2005;20:339-347.
39. Marti F, Krause A, Post NH, et al. Negative-feedback regulation of CD28 costimulation by a novel mitogen-activated protein kinase phosphatase, MKP6. J Immunol. 2001;166:197-206. (Pubitemid 32038433)
40. Harada Y, Ohgai D, Watanabe R, et al. A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS). J Exp Med. 2003;197:257-262. (Pubitemid 36152319)
41. Pei Y, Zhu P, Dang Y, et al. Nuclear export of NF90 to stabilize IL-2 mRNA is mediated by AKT-dependent phosphorylation at Ser647 in response to CD28 costimulation. J Immunol. 2008; 180:222-229.
42. Garcon F, Ghiotto M, Gerard A, Yang WC, Olive D, Nunes JA. The SH3 domain of Tec kinase is essential for its targeting to activated CD28 costimulatory molecule. Eur J Immunol. 2004; 34:1972-1980. (Pubitemid 39256078)
43. Marinari B, Costanzo A, Viola A, et al. Vav cooperates with CD28 to induce NF-κB activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1. Eur J Immunol. 2002;32:447-456. (Pubitemid 34173336)
44. Raab M, Pfister S, Rudd CE. CD28 signaling via VAV/SLP-76 adaptors: regulation of cytokine transcription independent of TCR ligation. Immunity. 2001;15:921-933. (Pubitemid 34075373)
45. Moller A, Dienz O, Hehner SP, Droge W, Schmitz ML. Protein kinase C θ cooperates with Vav1 to induce JNK activity in T-cells. J Biol Chem. 2001;276:20022-20028.
46. Annibaldi A, Sajeva A, Muscolini M, et al. CD28 ligation in the absence of TCR promotes RelA/NF-κB recruitment and transactivation of the HIV-1 LTR. Eur J Immunol. 2008;38:1446-1451.
47. Piccolella E, Spadaro F, Ramoni C, et al. Vav-1 and the IKK alpha subunit of IκB kinase functionally associate to induce NF-κB activation in response to CD28 engagement. J Immunol. 2003;170:2895-2903. (Pubitemid 36302160)
48. Blanchet F, Cardona A, Letimier FA, Hershfield MS, Acuto O. CD28 costimulatory signal induces protein arginine methylation in T cells. J Exp Med. 2005;202:371-377. (Pubitemid 41126954)
49. + T lymphocytes. Blood. 2006; 107:4841-4848. (Pubitemid 43882636)
50. Sanchez-Lockhart M, Miller J. Engagement of CD28 outside of the immunological synapse results in up-regulation of IL-2 mRNA stability but not IL-2 transcription. J Immunol. 2006;176: 4778-4784.
51. Pfeifhofer C, Gruber T, Letschka T, et al. Defective IgG2a/2b class switching in PKCα-/- mice. J Immunol. 2006;176:6004-6011.
52. Friend LD, Shah DD, Deppong C, et al. A dose-dependent requirement for the proline motif of CD28 in cellular and humoral immunity revealed by a targeted knockin mutant. J Exp Med. 2006;203:2121-2133. (Pubitemid 44352233)
53. Sanchez-Valdepenas C, Martin AG, Ramakrishnan P, Wallach D, Fresno M. NF-κB-inducing kinase is involved in the activation of the CD28 responsive element through phosphorylation of c-Rel and regulation of its transactivating activity. J Immunol. 2006;176:4666-4674.
54. Arestides RS, He H, Westlake RM, et al. Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation. Eur J Immunol. 2002;32:2874-2880. (Pubitemid 35238180)
55. Linton PJ, Bautista B, Biederman E, et al. Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo. J Exp Med. 2003;197:875-883. (Pubitemid 36437864)
56. Ito T, Amakawa R, Inaba M, et al. Plasmacytoid dendritic cells regulate Th cell responses through OX40 ligand and type I IFNs. J Immunol. 2004;172:4253-4259. (Pubitemid 38375238)
57. So T, Song J, Sugie K, Altman A, Croft M. Signals from OX40 regulate nuclear factor of activated T cells c1 and T cell helper 2 lineage commitment. Proc Natl Acad Sci U S A. 2006;103: 3740-3745. (Pubitemid 43376625)
58. Falk M, Ussat S, Reiling N, Wesch D, Kabelitz D, Adam-Klages S. Caspase inhibition blocks human T cell proliferation by suppressing appropriate regulation of IL-2, CD25, and cell cycle-associated proteins. J Immunol. 2004;173:5077-5085. (Pubitemid 39387790)
59. Schmidt-Weber CB, Wohlfahrt JG, Akdis CA, Blaser K. The phosphatidylinositol phosphatase PTEN is under control of costimulation and regulates proliferation in human T cells. Eur J Immunol. 2002;32:1196-1204. (Pubitemid 34428838)
60. Kissler S, Lu L, Cantor H. Thymic selection can compensate for mutations affecting T cell activation and generate a normal T cell repertoire in mutant mice. Proc Natl Acad Sci U S A. 2004;101:210-214. (Pubitemid 38084229)
61. Ye Q, Press B, Kissler S, et al. T cell costimulation through CD28 depends on induction of the Bcl-xγ isoform: analysis of Bcl-xγ-deficient mice. J Exp Med. 2002;196:87-95. (Pubitemid 34747314)
62. Bonnevier JL, Yarke CA, Mueller DL. Sustained B7/CD28 interactions and resultant phosphatidylinositol 3-kinase activity maintain G1-S phase transitions at an optimal rate. Eur J Immunol. 2006;36:1583-1597. (Pubitemid 43942146)
63. Colombetti S, Basso V, Mueller DL, Mondino A. Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin. J Immunol. 2006;176:2730-2738.
64. Appleman LJ, Chernova I, Li L, Boussiotis VA. CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation. Cell Cycle. 2006;5:2123-2129. (Pubitemid 44553747)
65. + T cell proliferation and effector function. J Immunol. 2005;174:3359-3368. (Pubitemid 40354040)
66. Appleman LJ, van Puijenbroek AA, Shu KM, Nadler LM, Boussiotis VA. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. J Immunol. 2002;168:2729-2736. (Pubitemid 34211650)
67. Rowell EA, Wang L, Hancock WW, Wells AD. The cyclindependent kinase inhibitor p27kip1 is required for transplantation tolerance induced by costimulatory blockade. J Immunol. 2006;177:5169-5176. (Pubitemid 44527589)
68. + T lymphocytes. J Immunol. 2005;174: 2481-2484. (Pubitemid 40279658)
69. Charvet C, Canonigo AJ, Becart S, et al. Vav1 promotes T cell cycle progression by linking TCR/CD28 costimulation to FOXO1 and p27kip1 expression. J Immunol. 2006;177:5024-5031. (Pubitemid 44527572)
70. Kovalev GI, Franklin DS, Coffield VM, Xiong Y, Su L. An important role of CDK inhibitor p18(INK4c) in modulating antigen receptor-mediated T cell proliferation. J Immunol. 2001; 167:3285-3292. (Pubitemid 32852569)
71. Marinari B, Costanzo A, Marzano V, Piccolella E, Tuosto L. CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-κB subunits on IL-8 and Bcl-xL gene promoters. Proc Natl Acad Sci U S A. 2004;101: 6098-6103. (Pubitemid 38520534)
72. Yang Y, Yang F, Xiong Z, et al. An N-terminal region of translationally controlled tumor protein is required for its antiapoptotic activity. Oncogene. 2005;24:4778-4788. (Pubitemid 41076295)
73. Graham DB, Bell MP, Huntoon CJ, et al. CD28 ligation costimulates cell death but not maturation of double-positive thymocytes due to defective ERK MAPK signaling. J Immunol. 2006;177:6098-6107. (Pubitemid 44628825)
74. Parry RV, Rumbley CA, Vandenberghe LH, June CH, Riley JL. CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes. J Immunol. 2003;171:166-174. (Pubitemid 36745285)
75. + T cells correlates with p27kip1 down-regulation and bcl-xL induction, and is prevented by an inhibitor of phosphoinositide 3-kinase activity. J Biol Chem. 2004;279:910-919. (Pubitemid 38082611)
76. Rogers PR, Song J, Gramaglia I, Killeen N, Croft M. OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity. 2001;15:445-455. (Pubitemid 32907391)
77. Gonzalez J, Orlofsky A, Prystowsky MB. A1 is a growthpermissive antiapoptotic factor mediating postactivation survival in T cells. Blood. 2003;101:2679-2685. (Pubitemid 36857630)
78. Alves NL, Derks IA, Berk E, Spijker R, van Lier RA, Eldering E. The Noxa/Mcl-1 axis regulates susceptibility to apoptosis under glucose limitation in dividing T cells. Immunity. 2006;24: 703-716. (Pubitemid 43867360)
79. Prell RA, Evans DE, Thalhofer C, Shi T, Funatake C, Weinberg AD. OX40-mediated memory T cell generation is TNF receptorassociated factor 2 dependent. J Immunol. 2003;171:5997-6005. (Pubitemid 37467218)
80. + T cell-mediated alloimmune responses in vivo. J Immunol. 2005;174:1357-1364.
81. + T cells by mitogenic human CD28 generates inflammatory cytokines and regulatory T cells. Eur J Immunol. 2008;38:1522-1532.
82. + T cells differ for acute and persistent phases of polyoma virus infection. J Immunol. 2006;176:1814-1824. (Pubitemid 43134326)
83. Zhang N, He YW. The antiapoptotic protein Bcl-xL is dispensable for the development of effector and memory T lymphocytes. J Immunol. 2005;174:6967-6973. (Pubitemid 40705661)
84. + memory T cell survival and significantly increases recall responses. Eur J Immunol. 2007; 37:157-166. (Pubitemid 46128796)
85. + T cell mobilization/memory development and humoral immunity: comparison of αOX-40 with αCTLA-4. J Immunol. 2001;167: 6804-6811. (Pubitemid 33144171)
86. Salek-Ardakani S, Song J, Halteman BS, et al. OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation. J Exp Med. 2003;198:315-324. (Pubitemid 36987856)
87. Jember AG, Zuberi R, Liu FT, Croft M. Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40. J Exp Med. 2001;193:387-392. (Pubitemid 32524521)
88. Song A, Tang X, Harms KM, Croft M. OX40 and Bcl-xL promote the persistence of CD8 T cells to recall tumorassociated antigen. J Immunol. 2005;175:3534-3541. (Pubitemid 41292011)
89. Song A, Song J, Tang X, Croft M. Cooperation between CD4 and CD8 T cells for anti-tumor activity is enhanced by OX40 signals. Eur J Immunol. 2007;37:1224-1232. (Pubitemid 46925307)